-
公开(公告)号：US5552143A
公开(公告)日：1996-09-03
申请号：US349006
申请日：1994-12-02
IPC分类号： A61K39/00 , C07K14/045 , C12N15/861 , A61K39/295 , A61K39/235 , A61K39/245
CPC分类号： C07K14/005 , C12N15/86 , A61K39/00 , C12N2710/10343 , C12N2710/16122 , C12N2710/16134 , C12N2810/6018
摘要： The present invention provides a non-defective adenovirus recombinant expression system for the expression of the HCMV gB subunit, an immunogenic fragment of the gB subunit, and for the expression of non-structural immediate-early exon 4 proteins, said recombinant HCMV-expressing adenovirus being useful as a vaccine.
摘要翻译： 本发明提供了用于表达HCMV gB亚基，gB亚单位的免疫原性片段和表达非结构立即早期外显子4蛋白的所述重组HCMV表达腺病毒的无缺陷型腺病毒重组表达系统 作为疫苗有用。
-
公开(公告)号：US5591439A
公开(公告)日：1997-01-07
申请号：US426673
申请日：1995-04-21
IPC分类号： A61K39/00 , C07K14/045 , C12N15/861 , A61K39/12 , A61K39/235 , A61K39/245
CPC分类号： C07K14/005 , C12N15/86 , A61K39/00 , C12N2710/10343 , C12N2710/16122 , C12N2710/16134 , C12N2810/6018
摘要： The present invention provides a non-defective adenovirus recombinant expression system for the expression of the HCMV gB subunit and for the expression of non-structural immediate-early exon 4 proteins, said recombinant HCMV-expressing adenovirus being useful as a vaccine.
摘要翻译： 本发明提供了用于表达HCMV gB亚基和用于表达非结构立即早期外显子4蛋白质的无缺陷型腺病毒重组表达系统，所述重组HCMV表达腺病毒可用作疫苗。
-
公开(公告)号：US20110294126A1
公开(公告)日：2011-12-01
申请号：US13195585
申请日：2011-08-01
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6883 , C12Q2600/142 , C12Q2600/156
摘要： The invention relates to kits and methods for assessing the susceptibility of a human to oxidative stress or damage. The methods involve assessing occurrence in the human's genome of one or more polymorphisms (e.g., single nucleotide polymorphisms) that occur in one or more genes associated with oxidative stress and that are associated with a disorder in humans. Preferred assessment and scoring methods are disclosed, as are kit for performing the methods.
摘要翻译： 本发明涉及用于评估人类对氧化应激或损伤的易感性的试剂盒和方法。 所述方法涉及评估人类基因组中发生在与氧化应激相关并与人类疾病相关的一个或多个基因中的一种或多种多态性（例如，单核苷酸多态性）的发生。 公开了优选的评估和评分方法，以及用于执行方法的试剂盒。
-
公开(公告)号：US20130011838A1
公开(公告)日：2013-01-10
申请号：US13546883
申请日：2012-07-11
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6883 , C12Q2600/142 , C12Q2600/156
摘要： The invention relates to kits and methods for assessing the susceptibility of a human to oxidative stress or damage. The methods involve assessing occurrence in the human's genome of one or more polymorphisms (e.g., single nucleotide polymorphisms) that occur in one or more genes associated with oxidative stress and that are associated with a disorder in humans. Preferred assessment and scoring methods are disclosed, as are kit for performing the methods.
摘要翻译： 本发明涉及用于评估人类对氧化应激或损伤的易感性的试剂盒和方法。 所述方法涉及评估人类基因组中发生在与氧化应激相关并与人类疾病相关的一个或多个基因中的一种或多种多态性（例如，单核苷酸多态性）的发生。 公开了优选的评估和评分方法，以及用于执行方法的试剂盒。
-
公开(公告)号：US08313930B2
公开(公告)日：2012-11-20
申请号：US11731180
申请日：2007-03-30
CPC分类号： C12Q1/6876 , C12Q1/6883 , C12Q2600/156
摘要： The invention relates to kits and methods for assessing skin health for a human and the human's susceptibility to skin disorders. The methods involve assessing occurrence in the human's genome of one or more polymorphisms (e.g., single nucleotide polymorphisms) that occur in one or more genes associated disclosed herein and that are associated with a disorder in humans. Preferred assessment and scoring methods are disclosed, as are kits for performing the methods.
摘要翻译： 本发明涉及用于评估人的皮肤健康和人类对皮肤病的易感性的试剂盒和方法。 所述方法涉及评估在人类基因组中发生在本文公开的一种或多种相关基因并且与人类疾病相关的一个或多个多态性（例如，单核苷酸多态性）中的发生。 公开了优选的评估和评分方法，以及用于执行方法的套件。
-
公开(公告)号：US08278342B2
公开(公告)日：2012-10-02
申请号：US12537083
申请日：2009-08-06
申请人： Robert P. Ricciardi
发明人： Robert P. Ricciardi
IPC分类号： A61K31/40
CPC分类号： A61K31/65 , A61K31/095 , A61K31/10 , A61K31/166 , A61K31/198 , A61K31/341 , A61K31/351 , A61K31/352 , A61K31/357 , A61K31/42 , A61K31/426 , A61K31/427 , A61K31/429 , A61K31/473 , A61K31/496 , A61K31/519
摘要： This invention provides methods of inhibiting replication of a poxvirus by contacting a poxvirus with a compound having formula XVII which in turn reduce, inhibit, or abrogate poxvirus DNA polymerase activity and/or its interaction with its processivity factor. Formula XVII can be utilized to treat humans and animals suffering from a poxvirus infection. Pharmaceutical compositions for treating poxvirus infected subjects are also provided.
摘要翻译： 本发明提供了通过使痘病毒与具有式XVII的化合物接触来抑制痘病毒复制的方法，其又减少，抑制或消除痘病毒DNA聚合酶活性和/或其与其活性因子的相互作用。 式XVII可用于治疗患有痘病毒感染的人和动物。 还提供了用于治疗痘病毒感染的受试者的药物组合物。
-
公开(公告)号：US07211383B2
公开(公告)日：2007-05-01
申请号：US10247935
申请日：2002-09-20
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6876 , C12Q1/6883 , C12Q2600/156
摘要： The invention relates to kits and methods for assessing skin health for a human and the human's susceptibility to skin disorders. The methods involve assessing occurrence in the human's genome of one or more polymorphisms (e.g., single nucleotide polymorphisms) that occur in one or more genes associated disclosed herein and that are associated with a disorder in humans. Preferred assessment and scoring methods are disclosed, as are kits for performing the methods.
-
8.发明申请METHODS FOR ASSESSING THE SUSCEPTIBILITY OF A HUMAN TO DIMINISHED HEALTH AND WELLNESS 审中-公开评估人类对维持健康和健康的不确定性的方法公开(公告)号：US20120164647A1
公开(公告)日：2012-06-28
申请号：US13415530
申请日：2012-03-08
申请人： Robert P. Ricciardi
发明人： Robert P. Ricciardi
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6827
摘要： The present invention relates to methods for assessing the advisability that a human should employ a compensatory composition comprised of one or more antioxidant ingredients. The methods involve assessing occurrence in the human's genome of a plurality of certain polymorphisms. Methods for determining the composition of preferred compensatory compositions are also disclosed.
摘要翻译： 本发明涉及用于评估人应该使用由一种或多种抗氧化成分组成的补偿性组合物的可取性的方法。 该方法涉及评估人类基因组中多种某些多态性的发生。 还公开了确定优选补偿组合物组成的方法。
-
9.发明申请Methods for Assessing the Susceptibility of a Human to Diminished Health and Wellness 审中-公开评估人类对健康和健康减退的敏感性的方法公开(公告)号：US20100304373A1
公开(公告)日：2010-12-02
申请号：US12541486
申请日：2009-08-14
申请人： Robert P. Ricciardi
发明人： Robert P. Ricciardi
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6827
摘要： The present invention relates to methods for assessing the advisability that a human should employ a compensatory composition comprised of one or more antioxidant ingredients. The methods involve assessing occurrence in the human's genome of a plurality of certain polymorphisms. Methods for determining the composition of preferred compensatory compositions are also disclosed.
摘要翻译： 本发明涉及用于评估人应该使用由一种或多种抗氧化成分组成的补偿性组合物的可取性的方法。 该方法涉及评估人类基因组中多种某些多态性的发生。 还公开了确定优选补偿组合物组成的方法。
-
公开(公告)号：US20090053343A1
公开(公告)日：2009-02-26
申请号：US12259528
申请日：2008-10-28
申请人： Robert P. Ricciardi
发明人： Robert P. Ricciardi
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6883 , C12Q2600/156
摘要： The invention relates to kits and methods for assessing susceptibility of a human to abnormal lipid metabolism and disorders associated therewith, such as obesity and diabetes. The methods involve assessing occurrence in the human's genome of one or more polymorphisms (e.g., single nucleotide polymorphisms) that occur in one or more genes associated with leptin-mediated lipid metabolism and that are associated with a disorder in humans. Preferred assessment and scoring methods are disclosed, as are kits for performing the methods.
摘要翻译： 本发明涉及用于评估人类与异常脂质代谢及其相关疾病如肥胖和糖尿病的易感性的试剂盒和方法。 所述方法涉及评估人类基因组中发生在与瘦蛋白介导的脂质代谢相关并且与人类疾病相关的一个或多个基因中发生的一个或多个多态性（例如，单核苷酸多态性）的发生。 公开了优选的评估和评分方法，以及用于执行方法的套件。
-
-
-
-
-
-
-
-
-
搜索结果
17 条记录 (耗时 0.027 秒)
